HALOZYME THERAPEUTICS INC. - US40637H1095 (Aktie)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
44
0
44
49,69 EUR
|
0,0604% |
29.07.2025 08:11
|
150,00 |
49,81 |
50,30 |
150,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
0
1
1
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
1
1
2
|
Halozyme Therapeutics Inc.
Sorrento Valley Road
92121, San Diego, CA, US
|
Telefon |
+1 858 794 8889 |
Fax |
+1 858 704 8311 |
E-Mail |
info@halozyme.com |
Internet |
http://www.halozyme.com
|
IR Kontakt/PR Kontakt |
-/- |
Symbol |
|
Ende des Geschäftsjahres |
31.12.2025 |
Marktkapitalisierung |
6.134.482.219,15 EUR |
/IBT-BA-HP/WEB-INF/snippets/root/company/contact.jsp
50
0
50
/IBT-BA-HP/WEB-INF/snippets/root/company/shareholders.jsp
1034
0
1034
Jeffrey Henderson |
Chairman of Board of Directors |
Akiko Miyashita |
Member of Board of Directors |
Barbara Duncan |
Member of Board of Directors |
Connie Matsui |
Member of Board of Directors |
Matthew Posard |
Member of Board of Directors |
Dr. Jean Bizzari |
Member of Board of Directors |
Bernadette Connaughton |
Member of Board of Directors |
/IBT-BA-HP/WEB-INF/snippets/root/company/board.jsp
41
0
41
/IBT-BA-HP/WEB-INF/snippets/root/company/corporateactions.jsp
38
1
39